| Arctic Chiropractic Valdez Llc | |
|
4000 W Dimond Blvd, Ste #4, Anchorage, AK 99502-1401 | |
| (907) 835-8777 | |
| (907) 835-8702 |
| Full Name | Arctic Chiropractic Valdez Llc |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 4000 W Dimond Blvd, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659611887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Provider Name | Edward J Foster |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1790827806 PECOS PAC ID: 1557679032 Enrollment ID: I20151002002146 |
News Archive
DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the closing of a $36.2 million round of equity financing. The round was led by new investor Split Rock Partners. Funding was also contributed by new investor OrbiMed, and inside investors Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, Highland Capital Management and several private investors.
More Americans—especially those with chronic conditions such as diabetes, asthma and depression-are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.
Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).
› Verified 8 days ago
| Provider Name | Lewis Pagel |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1497851372 PECOS PAC ID: 6406897628 Enrollment ID: I20171009002617 |
News Archive
DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the closing of a $36.2 million round of equity financing. The round was led by new investor Split Rock Partners. Funding was also contributed by new investor OrbiMed, and inside investors Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, Highland Capital Management and several private investors.
More Americans—especially those with chronic conditions such as diabetes, asthma and depression-are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.
Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).
› Verified 8 days ago
| Provider Name | Ryan B Manns |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1497414510 PECOS PAC ID: 5395132864 Enrollment ID: I20220502001185 |
News Archive
DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the closing of a $36.2 million round of equity financing. The round was led by new investor Split Rock Partners. Funding was also contributed by new investor OrbiMed, and inside investors Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, Highland Capital Management and several private investors.
More Americans—especially those with chronic conditions such as diabetes, asthma and depression-are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.
Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arctic Chiropractic Valdez Llc 4000 W Dimond Blvd, Ste #4, Anchorage, AK 99502-1401 Ph: (907) 835-8777 | Arctic Chiropractic Valdez Llc 4000 W Dimond Blvd, Ste #4, Anchorage, AK 99502-1401 Ph: (907) 835-8777 |
News Archive
DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the closing of a $36.2 million round of equity financing. The round was led by new investor Split Rock Partners. Funding was also contributed by new investor OrbiMed, and inside investors Prospect Venture Partners, Vanguard Ventures, BBT Fund/Apothecary Capital, Highland Capital Management and several private investors.
More Americans—especially those with chronic conditions such as diabetes, asthma and depression-are going without prescription drugs because of cost concerns, according to a new national study by the Center for Studying Health System Change (HSC).
For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.
Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).
› Verified 8 days ago
Arctic Chiropractic Barrow Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 4000 W Dimond Blvd, Ste #4, Anchorage, AK 99502 Phone: 907-852-3099 Fax: 907-852-3225 | |
Chiro One Wellness Center Of Anchorage South Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 4000 W Dimond Blvd Unit 4, Anchorage, AK 99502 Phone: 907-243-0660 | |
Dr. Jonathan D. Vito, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8840 Old Seward Hwy Ste E, Anchorage, AK 99515 Phone: 907-346-5255 Fax: 907-346-5256 | |
Arctic Rehabilitation And Physical Therapy Anchorage Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 5701 Lake Otis Pkwy, Suite 100, Anchorage, AK 99507 Phone: 907-277-3422 | |
Dr. Kelly Brian Ryan, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 550 E Tudor Rd, Anchorage, AK 99503 Phone: 907-222-2100 Fax: 907-222-2131 | |
Dr. Elliott Shawn Woodmansee, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 750 W Dimond Blvd, Suite 121, Anchorage, AK 99515 Phone: 907-344-0033 Fax: 907-344-6332 | |
Dr. Wesley Moore, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 505 W Northern Lights Blvd, Anchorage, AK 99503 Phone: 907-339-0100 Fax: 907-334-1961 |